Stromal Sarcoma — Trials

Stromal Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 40%
Top sponsor: Centre Leon Berard
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03139487	A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism(PRIORITY)	unknown	Phase 2	176	Asan Medical CenterOTHER	1	Jan 6, 2020	clinicaltrials
NCT03171389	POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST(POETIG)	unknown	Phase 2	81	Sebastian BauerOTHER	1	May 31, 2017